PL3290405T3 - Sól kwasu mesylowego związku acylotiomocznika, jej kryształ oraz sposoby jej wytwarzania - Google Patents
Sól kwasu mesylowego związku acylotiomocznika, jej kryształ oraz sposoby jej wytwarzaniaInfo
- Publication number
- PL3290405T3 PL3290405T3 PL16786581T PL16786581T PL3290405T3 PL 3290405 T3 PL3290405 T3 PL 3290405T3 PL 16786581 T PL16786581 T PL 16786581T PL 16786581 T PL16786581 T PL 16786581T PL 3290405 T3 PL3290405 T3 PL 3290405T3
- Authority
- PL
- Poland
- Prior art keywords
- crystal
- acid salt
- production processes
- mesylic acid
- processes therefor
- Prior art date
Links
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015092815 | 2015-04-30 | ||
| PCT/JP2016/063413 WO2016175305A1 (ja) | 2015-04-30 | 2016-04-28 | アシルチオウレア化合物のメシル酸塩及びその結晶並びにそれらの製造方法 |
| EP16786581.5A EP3290405B1 (en) | 2015-04-30 | 2016-04-28 | Mesylic acid salt of acylthiourea compound, crystal thereof, and production processes therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3290405T3 true PL3290405T3 (pl) | 2021-07-12 |
Family
ID=57199144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16786581T PL3290405T3 (pl) | 2015-04-30 | 2016-04-28 | Sól kwasu mesylowego związku acylotiomocznika, jej kryształ oraz sposoby jej wytwarzania |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10143688B2 (pl) |
| EP (1) | EP3290405B1 (pl) |
| JP (1) | JP6676626B2 (pl) |
| CN (1) | CN107614489B (pl) |
| DK (1) | DK3290405T3 (pl) |
| ES (1) | ES2863586T3 (pl) |
| HU (1) | HUE054405T2 (pl) |
| PL (1) | PL3290405T3 (pl) |
| PT (1) | PT3290405T (pl) |
| WO (1) | WO2016175305A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3583943T3 (da) | 2017-02-15 | 2024-10-14 | Taiho Pharmaceutical Co Ltd | Farmaceutisk sammensætning |
| KR102584306B1 (ko) | 2017-09-08 | 2023-10-04 | 다이호야쿠힌고교 가부시키가이샤 | 항종양제 및 항종양 효과 증강제 |
| MA53667A (fr) | 2018-09-18 | 2021-07-28 | Taiho Pharmaceutical Co Ltd | Polythérapie associant un composé d'acylthiourée et de l'abiratérone |
| TWI872203B (zh) * | 2020-02-14 | 2025-02-11 | 日商大鵬藥品工業股份有限公司 | 醯基硫脲化合物的製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010011097A (es) * | 2008-04-10 | 2010-11-01 | Taiho Pharmaceutical Co Ltd | Compuesto de aciltiourea o sal del mismo, y uso del mismo. |
| TWI594986B (zh) * | 2011-12-28 | 2017-08-11 | Taiho Pharmaceutical Co Ltd | Antineoplastic agent effect enhancer |
| US9149471B2 (en) | 2013-09-30 | 2015-10-06 | National University Corporation Tokyo University Of Agriculture And Technology | Therapeutic agent for osteoporosis |
-
2016
- 2016-04-28 WO PCT/JP2016/063413 patent/WO2016175305A1/ja not_active Ceased
- 2016-04-28 DK DK16786581.5T patent/DK3290405T3/da active
- 2016-04-28 JP JP2017515618A patent/JP6676626B2/ja active Active
- 2016-04-28 PT PT167865815T patent/PT3290405T/pt unknown
- 2016-04-28 EP EP16786581.5A patent/EP3290405B1/en active Active
- 2016-04-28 US US15/570,021 patent/US10143688B2/en active Active
- 2016-04-28 CN CN201680024210.1A patent/CN107614489B/zh active Active
- 2016-04-28 PL PL16786581T patent/PL3290405T3/pl unknown
- 2016-04-28 HU HUE16786581A patent/HUE054405T2/hu unknown
- 2016-04-28 ES ES16786581T patent/ES2863586T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3290405A1 (en) | 2018-03-07 |
| EP3290405B1 (en) | 2021-02-17 |
| HK1247200A1 (zh) | 2018-09-21 |
| CN107614489A (zh) | 2018-01-19 |
| JPWO2016175305A1 (ja) | 2018-04-12 |
| EP3290405A4 (en) | 2018-09-12 |
| CN107614489B (zh) | 2021-05-11 |
| US20180161317A1 (en) | 2018-06-14 |
| DK3290405T3 (da) | 2021-03-22 |
| ES2863586T3 (es) | 2021-10-11 |
| JP6676626B2 (ja) | 2020-04-08 |
| WO2016175305A1 (ja) | 2016-11-03 |
| PT3290405T (pt) | 2021-03-23 |
| HUE054405T2 (hu) | 2021-09-28 |
| US10143688B2 (en) | 2018-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262138A (en) | Cell-free production of ribonucleic acid | |
| GB2550003B (en) | Process for the production of formaldehyde-stabilised urea | |
| IL249415B (en) | Electrolytic production of ammonia | |
| HUE059116T2 (hu) | Eljárás alkálifém-szulfátsó elõállítására | |
| EP3256439A4 (en) | Process for production of acrylic acid | |
| SG11201707370WA (en) | Cell-free production of ribonucleic acid | |
| HUE051416T2 (hu) | Anilin elõállítása antranilát útján | |
| HUE051968T2 (hu) | Elektrolit elõállítási eljárás | |
| HUE051839T2 (hu) | Elektrolit elõállítási eljárás | |
| GB201516516D0 (en) | Process of manufacture | |
| GB201518792D0 (en) | Production of proteins | |
| HUE059670T2 (hu) | Eljárás új nitrogén-tartalmú vegyület vagy sója és intermedierjei elõállítására | |
| EP3315827A4 (en) | Process for production of gaskets | |
| PL3262023T3 (pl) | Sposób wytwarzania dienów | |
| EP3323166A4 (en) | AUTOMATED MANUFACTURE OF A BIONANO CATALYST | |
| ZA201701003B (en) | Process for the production of a pgm-enriched alloy | |
| HUP1700197A2 (en) | Industrial procedure for production of cariprazine | |
| HUE044577T2 (hu) | Eljárás karbamid elõállítására | |
| DK3200779T3 (en) | Novel anthranilic acid derivatives | |
| ZA201801991B (en) | Process for the preparation of monochloroacetic acid | |
| PT3290405T (pt) | Sal de ácido mesílico de composto de aciltioureia, cristal do mesmo, e respetivos processos de produção | |
| PL3271325T3 (pl) | Sposób wytwarzania (S)-metolachloru | |
| ZA201800909B (en) | Process for the recovery of hydrochloric acid | |
| GB2555726B (en) | Urea production method | |
| GB201416909D0 (en) | Method of forming concentrated solution |